← Back to headlines
BridgeBio Shares Rise on Reported Settlement in Pfizer Vyndamax Patent Dispute
BridgeBio's stock saw gains following reports of a settlement in a patent dispute involving Pfizer's drug Vyndamax.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Two Airport Workers Die of Malaria After Mosquito Bite Linked to Aircraft
15m ago
Busy Philipps Reveals She Underwent Surgery to Remove Rare Brain Tumor
30m ago
Closing Arguments Set as Murder Trial of Chris Benoit Nears Conclusion
36m ago
Eight-Year-Old Boy Dies After Electric Shock From Water Cooler in UAE
40m ago